Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.

MLA

Hase, Tetsunari, et al. “Short Hydration with 20 MEq of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy: A Prospective Study.” International Journal of Clinical Oncology, vol. 25, no. 11, Nov. 2020, pp. 1928–35. EBSCOhost, https://doi.org/10.1007/s10147-020-01755-1.

APA

Hase, T., Miyazaki, M., Ichikawa, K., Yogo, N., Ozawa, N., Hatta, T., Ando, M., Sato, M., Kondo, M., Yamada, K., & Hasegawa, Y. (2020). Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study. International Journal of Clinical Oncology, 25(11), 1928–1935. https://doi.org/10.1007/s10147-020-01755-1

Chicago

Hase, Tetsunari, Masayuki Miyazaki, Kazuya Ichikawa, Naoyuki Yogo, Naoya Ozawa, Takahiro Hatta, Masahiko Ando, et al. 2020. “Short Hydration with 20 MEq of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy: A Prospective Study.” International Journal of Clinical Oncology 25 (11): 1928–35. doi:10.1007/s10147-020-01755-1.